US Supreme Court Unanimously Sides with Marijuana Consumer Limits Federal Law on Possession

The U.S. Supreme Court ruled unanimously on June 18, 2026, to limit the application of the federal ban on firearm possession for marijuana users. The decision restricts how federal authorities enforce firearm prohibitions against individuals who use cannabis in jurisdictions where the practice is legal.

How does this ruling change federal firearm laws?

The ruling narrows the scope of the Gun Control Act of 1968, which prohibits any person who is an “unlawful user of a controlled substance” from shipping, transporting, receiving, or possessing firearms or ammunition. Under this federal statute, marijuana remains a Schedule I controlled substance, meaning users were previously barred from firearm ownership regardless of their state’s legal status.

The court’s decision limits the federal government’s ability to define “unlawful user” in a way that overrides state-level legalization. By doing so, the court reduces the legal jeopardy for cannabis consumers in states where the drug is legal for medical or recreational use, provided they comply with state regulations.

Why did the Supreme Court limit the ban?

The court addressed the inherent conflict between the federal Controlled Substances Act and the laws of various U.S. states. Because marijuana is legal in a significant number of states, the court found that a blanket federal ban on firearm possession for these users created an untenable legal contradiction.

The justices focused on the definition of “unlawful.” According to the ruling, the term cannot be applied arbitrarily to individuals who are acting in accordance with the laws of their own state. This interpretation prevents the federal government from using a secondary law—firearm possession—to punish a behavior that a state has explicitly decriminalized or legalized.

What happens to marijuana users in legal states?

Individuals residing in states where marijuana is legal now have a stronger legal defense against federal firearm charges based solely on their status as cannabis users. The ruling does not legalize marijuana at the federal level, nor does it remove the drug from the Schedule I list. However, it separates the act of using marijuana from the automatic loss of Second Amendment rights.

Legal experts note that this decision aligns with the precedent set in New York State Rifle & Pistol Association, Inc. v. Bruen, which required firearm regulations to be consistent with the nation’s historical tradition of firearm regulation. The court found that a total ban on firearm possession for users of a substance that is legal under state law did not meet this historical standard.

How does this contrast with previous federal enforcement?

Prior to June 18, 2026, the Department of Justice and the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) maintained that any use of marijuana rendered a person an “unlawful user” under federal law. This meant that even if a person had a valid state medical marijuana card, they could face federal felony charges for possessing a firearm.

The current ruling creates a distinction between “unlawful” use and “state-authorized” use. This shift moves the burden of proof to the government to show that a user’s possession of a firearm is illegal for reasons beyond their adherence to state cannabis laws.

What are the remaining legal restrictions?

The ruling does not grant universal firearm rights to all marijuana users. Federal restrictions still apply in several scenarios:

• Individuals who use marijuana in states where it remains illegal are still considered “unlawful users” and are barred from firearm possession.
• The ruling does not affect other controlled substances, such as heroin or cocaine, which remain strictly prohibited.
• Federal firearm bans for those with felony convictions or specific mental health adjudications remain in effect.

The decision leaves the broader question of marijuana’s federal classification to Congress and the Drug Enforcement Administration (DEA). While the firearm ban is now limited, the drug’s status as a Schedule I substance continues to affect employment, banking, and interstate commerce.